ScholarIQanswers from OpenAlex & ORCID
Michael Michael
ResearcherPublications, citations & collaboration network
Michael Michael is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michael Michael have?
ScholarIQindexed works
Michael Michael has 297 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael Michael have?
ScholarIQcitation count
Michael Michael has 7,292 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michael Michael?
ScholarIQh-index
Michael Michael has an h-index of 45 in OpenAlex.
What is the i10-index of Michael Michael?
ScholarIQi10-index
Michael Michael has an i10-index of 106 in OpenAlex.
What is the ORCID of Michael Michael?
ScholarIQorcid
The ORCID for Michael Michael is on the source record.
What is the OpenAlex record for Michael Michael?
ScholarIQopenalex
The OpenAlex for Michael Michael is on the source record.
What are the most-cited papers on Michael Michael?
ScholarIQmost cited works
<i>MET</i> Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
Jochen K. Lennerz, Eunice L. Kwak, A. B. Ackerman, Michael Michael, Stephen B. Fox, Kristin Bergethon, Gregory Y. Lauwers, James G. Christensen, Keith D. Wilner, Daniel A. Haber, Ravi Salgia, Yung‐Jue Bang, Jeffrey W. Clark, Benjamin Solomon, A. John Iafrate
Adjunctive Systemic Hyperbaric Oxygen Therapy in Treatment of Severe Prevalently Ischemic Diabetic Foot Ulcer: A randomized study
Ezio Faglia, Favales Favales, Aldeghi Aldeghi, Patrizia Calia, Antonella Quarantiello, G. Oriani, Michael Michael, Pietro Campagnoli, Alberto Morabito
Bridging Bio–Nano Science and Cancer Nanomedicine
Mattias Björnmalm, Kristofer J. Thurecht, Michael Michael, Andrew M. Scott, Frank Caruso
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG
Trevor Leong, B. Mark Smithers, Karin Haustermans, Michael Michael, Val Gebski, Danielle Miller, John Zalcberg, Alex Boussioutas, Michael Findlay, Rachel O’Connell, Jaclyn Verghis, David J. Willis, Tomas Kron, Melissa Crain, William K. Murray, Florian Lordick, Carol J. Swallow, Gail Darling, John Simes, Rebecca Wong
Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers
Oliver Klein, Damien Kee, Adnan Nagrial, Ben Markman, Craig Underhill, Michael Michael, Louise Jackett, Caroline Lum, Andreas Behren, Jodie Palmer, Niall C. Tebbutt, Matteo S. Carlino, Jonathan Cebon